Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/17/2008EP2001476A2 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
12/17/2008EP2001475A2 Methods for treating sarcopenia with a growth hormone secretagogue
12/17/2008EP2001474A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/17/2008EP2001472A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/17/2008EP2001471A1 Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders
12/17/2008EP2001470A2 Combination therapies of thiazolidinedione analogues
12/17/2008EP2001469A2 Thiazolidinedione analogues
12/17/2008EP2001468A2 Thiazolidinedione analogues
12/17/2008EP2001467A2 Spirocyclic heterocyclic derivatives and methods of their use
12/17/2008EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions
12/17/2008EP2001465A1 Antibiotic compositions of modified release and process of production thereof
12/17/2008EP2001464A2 Duloxetine salts
12/17/2008EP2001463A1 A pharmaceutical composition useful as acetyl cholinesterase inhibitors
12/17/2008EP2001462A2 Inhibition of microtubule protrusion in cancer cells
12/17/2008EP2001461A2 Combination treatment of metabolic disorders
12/17/2008EP2001460A2 Compositions for promoting hair growth
12/17/2008EP2001458A1 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
12/17/2008EP2001457A1 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
12/17/2008EP2001456A2 Use of kappa opioid receptor antagonist-containing compositions for the treatment of dissociative disorders
12/17/2008EP2001455A2 Methods of treating muscular wasting diseases using nf-kb activation inhibitors
12/17/2008EP2001454A2 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
12/17/2008EP2001449A2 Modified release clopidogrel formulation
12/17/2008EP2001448A2 Flavor-enhancing compositions, methods of manufacture, and methods of use
12/17/2008EP2001446A2 Formulations of sitaxsentan sodium
12/17/2008EP2001445A1 Pharmaceutical spheroids
12/17/2008EP2001444A2 Coated formulations for tolterodine
12/17/2008EP2001441A2 Cancer treatments
12/17/2008EP2001440A1 Biguanide-containing liposomes
12/17/2008EP2001438A2 Stable formulations, and methods of their preparation and use
12/17/2008EP2001350A2 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
12/17/2008EP2001313A2 Antimicrobial preparations
12/17/2008EP2001302A2 Pharmaceutical formulations containing metformin
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP2001293A2 Use of ketogenic compounds for treatment of age-associated memory impairment
12/17/2008EP1922061B1 Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin
12/17/2008EP1919883B1 N-oxides as prodrugs of piperazine&piperidine derivatives
12/17/2008EP1917233B1 Anilinohexafluoroisopropanol compounds
12/17/2008EP1843791A4 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1773829B1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1763369B1 Combinations comprising antimuscarinic agents and corticosteroids
12/17/2008EP1763342B1 Sphingolipids against pathological processes in lipid rafts
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008EP1751272B1 Production of tacrolimus (fk-506) using new streptomyces species
12/17/2008EP1742950B1 Pyrazolo[4,3-d] pyrimidines
12/17/2008EP1722780A4 A method of preventing or treating glaucoma
12/17/2008EP1716153A4 Methods, compositions, and apparatuses for forming macrocyclic compounds
12/17/2008EP1703896B1 Pharmaceutical compositions comprising midazolam in a high concentration
12/17/2008EP1684744A4 Pyrrolidine and piperidine derivatives as factor xa inhibitors
12/17/2008EP1673360B1 Furan derivatives as ep4 receptor antagonists
12/17/2008EP1673083A4 N-substituted azacycles
12/17/2008EP1651623B1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/17/2008EP1639903B1 Composition and foods for lowering glycemic index
12/17/2008EP1628622A4 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
12/17/2008EP1610796A4 High potency dopaminergic treatment of neurological impairment associated with brain injury
12/17/2008EP1603919B1 7-imino derivatives of camptothecin having antitumor activity
12/17/2008EP1572695B1 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy
12/17/2008EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity
12/17/2008EP1532131B1 Motilide compounds
12/17/2008EP1509234B1 Treatment of mucositis
12/17/2008EP1503759B1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
12/17/2008EP1465914B1 Triterpene quaternary salts as biologically active surfactants
12/17/2008EP1453489A4 Acetaminophen compositions
12/17/2008EP1450739A4 Hydrating nasal gel and applicator
12/17/2008EP1448186B1 Medicament for the treatment of viral skin and tumour diseases
12/17/2008EP1443046B1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008EP1423106B1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity
12/17/2008EP1417176B1 Substituted anthranilamides for controlling invertebrate pests
12/17/2008EP1385504B1 Method of inhibiting adhesion formation
12/17/2008EP1377284B1 Controlled release arginine formulations
12/17/2008EP1369119B1 Il-12 expression controlling agents
12/17/2008EP1330244B1 Compositions comprising modafinil compounds
12/17/2008EP1322654B1 Platinum complexes as antitumour agents
12/17/2008EP1282609B1 Piperazinedione compounds
12/17/2008EP1274449B1 Methods for manipulating upper gastrointestinal transit, blood flow, for inducing satiety
12/17/2008EP1255742B1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
12/17/2008EP1251738B1 Novel diphenylethylene compounds
12/17/2008EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
12/17/2008EP1229917B1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
12/17/2008EP1198458B1 Ceramide analogs, process for their preparation and their use as antitumor agents
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008EP1012250B1 Regulation of gene expression in plants
12/17/2008EP1007673B1 Novel bone mineralization proteins, dna, vectors, expression systems
12/17/2008EP0859603B1 Sustained release matrix for high-dose insoluble drugs
12/17/2008CN101326287A RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
12/17/2008CN101326286A Anti-myosin va siRNA and skin depigmentation
12/17/2008CN101326285A RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders
12/17/2008CN101326284A Method for enriching short-chain nucleic acids
12/17/2008CN101326192A Novel dihydropseudoerythromycin derivatives
12/17/2008CN101326191A Phosphine transition metal complex, method for producing same and antitumor agent containing same
12/17/2008CN101326188A Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2A]pyrazin-1-one compounds
12/17/2008CN101326187A Pyrrolo[2,3-c]pyridine derivatives
12/17/2008CN101326186A Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
12/17/2008CN101326185A Aryl acetic acid and ester derivatives and their uses as antiinflammatory
12/17/2008CN101326184A Bis-heterocyclic imidazolyl compounds
12/17/2008CN101326183A Bicyclic heterocyclic compounds as antiinflammatory agents
12/17/2008CN101326182A 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
12/17/2008CN101326181A Imidazopyridine derivatives as a2b adenosine receptor antagonists
1 ... 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 ... 7860